ACN Newswire

Tue Dec 3

Eisai to Present Latest Data on Alzheimer's Disease / Dementia Pipeline at 12th Clinical Trials on Alzheimer's Disease Conference

Written by ACN Newswire

TOKYO, Dec 2, 2019 - (JCN Newswire) - Eisai Co., Ltd. announced today that three oral presentations and eight poster presentations, highlighting the latest data on its Alzheimer's disease / dementia pipeline including anti-amyloid beta (Abeta) protofibril antibody BAN2401, orexin receptor antagonist lemborexant and a simple blood diagnostic for...

ACN Newswire

Eisai to Present Latest Data on Alzheimer's Disease / Dementia Pipeline at 12th Clinical Trials on Alzheimer's Disease Conference

Costs to budget for when opening your opening medical practice

Religious groups are embracing technology during the lockdown, but can it replace human connection?

Hazing and sexual violence in Australian universities: we need to address men's cultures

Why people born between 1966 and 1994 are at greater risk of measles – and what to do about it

Science or Snake Oil: is glucosamine good for joints?

What is hypnobirthing, the technique the Duchess of Cambridge used?

Prisoners need drug and alcohol treatments but AA programs aren't the answer

Online tools can help people in disasters, but do they represent everyone?

View from The Hill: Breaking Pauline Hanson's 'strike' has taken skin off Bridget McKenzie

Asylum seekers left 'desperate' and 'helpless' when they try to find work in Australia

Head On Festival review: every photograph tells a virtual story